Business Strategy
The Activaero business model rests upon the company's unique device technology for inhalant drug delivery. The strategy to market this technology consists of theree different approaches.
Selling approved Inhalation systems
One approach focuses on development and sales of innovative next generation inhalation systems. With tomorrow in mind, Activaero plans to offer device solutions for wireless data communication and remote monitoring which will open the door for improved economics in healthcare. At the same time we work on the miniaturization of our technology as the outpatient treatment will require more and more small and mobile devices.
Licencing/Partnering with pharma and biotech companies
Another important goal for Activaero is to license our technologies and aerosol services to biotech and pharma companies. This offers us the opportunity to participate in the value creating development and marketing of new inhalant drugs.
Clinical development of innovative therapies
Furthermore we have started our own clinical programs of low risk clinical drug development. These involve well-known medications for inhalant delivery to lungs that our own inhalation technology and will result in us, developing and marketing new therapeutic advances.